All articles by Henry Kerali

  1. Expert Insights: Serialization is a Necessary Step to Pharma Industry’s Adoption of Blockchain

    Implementation of electronic serialization is needed before blockchain can be adopted by the pharmaceutical industry, an expert has said. Blockchain…
    Read More…

    17 Aug
  2. Industry Viewpoints: Effectively Outsourcing Early Phase Clinical Trials

    In recent times, trial sponsors have increasingly turned to running clinical trials abroad to benefit from an increase in patient…
    Read More…

    15 Aug
  3. Considerations for Manufacturing Investigational Medicinal Products for Clinical Studies

    Manufacturing drug products for clinical studies present many unique challenges that contrast to the manufacturing of commercial drug products. This…
    Read More…

    13 Aug
  4. How to Maximize Randomization and Trial Management Systems in Clinical Studies

    Running a clinical trial is getting increasingly complex and costly, regardless of the size of the company. While carrying out…
    Read More…

    9 Aug
  5. Tech Giants Tackle Health Care: An Opportunity or Threat for the Pharmaceutical Industry?

    The health care space is undergoing a major transformation, driven in part by Big Tech entering the space. The past…
    Read More…

    7 Aug
  6. Social Media and Clinical Trials – Is the Hype all it’s made out to be?

    Adrian Orr is currently the Director of Clinical Affairs at Anika Therapeutics, Inc. Having spent many years conducting trials both…
    Read More…

    6 Aug
  7. The Top 5: July 2018

    There were numerous articles in July 2018 that covered a wide range of topical issues. Here are five of the…
    Read More…

    3 Aug
  8. Immuno-Oncology and Combination Trials: New Aspirations, Old Frustrations

    In 2001, the approval of Imatinibmesylate (Gleevec– Novartis) to treat chronic myeloid leukemia (CML) launched the modern era of targeted…
    Read More…

    1 Aug
  9. Biopharmaceuticals and the DACH Region: The Availability of Patients in Austria, Germany and Switzerland

    Succeeding in clinical development isn’t an easy task to accomplish. A notoriously complex and expensive process lasting anywhere between 5–15…
    Read More…

    31 Jul
  10. Expert Insights: The Future of Drug Discovery Looks to be in the Hands of Artificial Intelligence

    The applications of artificial intelligence (AI) in health care are numerous, with the potential to transform key aspects of the…
    Read More…

    30 Jul